RE:RE:"Nitrogen Scavenging Properties" Liminal's job is to make as much money and profit as they can for Thomvest, their owners, that’s business 101.
If they need to misinform, misrepresent, and distort reality to accomplish their outcome they will. If it's better for them to screw investors they will without a second thought. If it's better to twist the branding of PBI 4050 to disconnect themselves from this billion dollar lawsuit they face, again they will! We all know how revolutionary PBI 4050 was from what Prometic was pumping. Did that all just go away? Dr. Moran quoted it as being the next penicillin. We saw the IPF results, outstanding compared with other leading drugs.
We all know very well how underhanded and unethical these players are, shouldn't be surprised with the games they are playing now.
stockbuphoon wrote:
This study result was 100% telegraphed and expected that they would tank 4050 despite the early success in fibrosis on Alstrom and IPF. So, someone is lying. Was it previous management of Pierre Laurin and Dr John Moran or was it Thomvest / current management who recapitalized PLi? With many trials completed previously with top scientists, they found strong fibrosis candidates. Now, with a technical team led by a consultant, it takes 15 months to deduce that there is no value to 4050 as a fibrosis drug?
if they knew there was no value to 4050 in fibrosis, why would they give Pierre Laurin's company $400k and a royalty stream for the IP last month? Why would Thomvest get rid of their top scientists like Lynn Gagnon who led 4050 development when small molecule division was where their focus would be. As usual, something is rotten in the state of PLI.
37minus4 wrote: Well that is some thin gruel, boy.
Maybe they can add some of their "scavenged nitrogen" to the poutine in the poutine shack.
Tasty.
;-/
33